Russell is the Chairman, CEO, and the lead inventor of E-SENSE core technology, and sets the vision, mission, and strategic direction of the company. His focus is the research, development, application, and commercialization of state-of-the-art multi-modal and multi-scale biomedical imaging devices to advance biotechnology and quality of life. Russell is also a senior consultant at COCHE (Hong Kong Center for Cerebro-cardiovascular Health Engineering). He is the ex-co and R&D focus group lead of HKIE BMD (Hong Kong Institute of Engineers Biomedical Division). He is the founding Vice-Chair of the Young Member Section at HKAE (Hong Kong Academy of Engineering). He was Vice President of BIOHK (Hong Kong International Biotechnology Convention). He is the recipient of the highly selective HKEST award and REVIVE CTO of the Year in 2023. Russell is an elected Junior Fellow of ISMRM (International Society of Magnetic Resonance in Medicine), and an elected Young Fellow of HKAE (Hong Kong Academy of Engineering).

Russell Holds a B.Eng. in biomedical engineering and Ph.D. in electrical and electronic engineering from The University of Hong Kong (HKU). He was a post-doctoral research fellow at Stanford University in Neurology and Neurological Sciences, and New York University in Neuroscience, Tech4Health, and Ophthalmology.

Jimmy is the CFO of E-SENSE, oversees all accounting, financial and investment-related operations. With extensive experience gained from working at PricewaterhouseCoopers, Jimmy has developed a profound expertise in capital market transactions including initial public offerings, mergers and acquisitions, and debt offerings. In addition, Jimmy has played an integral role in delivering auditing and assurance services as well as transfer pricing tax services to a diverse portfolio of multinational companies spanning various industries.

Jimmy holds a Master of Commerce degree with a major in finance from the University of New South Wales, Australia and is a member of the CPA Australia.